Pseudomonas aeruginosa Serious Infections: Mono or Combination Antimicrobial Therapy?

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|15|5|517-522

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.5, 2008-02, pp. : 517-522

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Appropriate antibacterial therapy is crucial in the management of Pseudomonas aeruginosa infections

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 10, 2007-10 ,pp. : 14-16

Adis International

Access to resources Recommend Favorite

The Implication of Pseudomonas aeruginosa Biofilms in Infections

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 2, 2011-04 ,pp. : 141-157

Bentham Science Publishers

Access to resources Recommend Favorite

The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections

By Driscoll James A.   Brody Steven L.   Kollef Marin H.  

Drugs, Vol. 67, Iss. 3, 2007-01 ,pp. : 351-368

Adis International

Access to resources Recommend Favorite

Modern Therapeutic Approaches Against Pseudomonas aeruginosa Infections

By  

Current Medicinal Chemistry, Vol. 22, Iss. 14, 2015-05 ,pp. : 1642-1664

Bentham Science Publishers

Access to resources Recommend Favorite

Levofloxacin and Indolicidin for Combination Antimicrobial Therapy

By  

Current Drug Delivery, Vol. 12, Iss. 1, 2015-02 ,pp. : 108-114

Bentham Science Publishers

Access to resources Recommend Favorite